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Fundus autoﬂuorescence (FAF) is a non-invasive imaging technique that enables the visualization of lipofuscin changes in the retinal
pigment epithelium. This study aims to illustrate the spectrum of FAF changes in a variety of retinal dystrophies. For this purpose, we
examined patients with retinal dystrophies such as Stargardt disease, Best vitelliform macular dystrophy, and retinal dystrophies asso-
ciated with mutations in the peripherin/RDS gene. All retinal dystrophies were conﬁrmed by molecular genetic analysis. A broad range of
characteristic FAF patterns was observed. Our results indicate that FAF imaging constitutes a useful additive tool in the diagnosis and
follow-up of various retinal dystrophies.
 2008 Elsevier Ltd. All rights reserved.
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During the last decade, fundus autoﬂuorescence
(FAF) imaging of the retina has emerged as a useful,
non-invasive imaging technique in the diagnosis and fol-
low-up of several retinal dystrophies (Robson et al.,
2006; von Ru¨ckmann, Fitzke, & Bird, 1997, 1999; Wab-
bels, Preising, Kretschmann, Demmler, & Lorenz, 2006b;
Wabbels et al., 2006a). Obtaining suﬃcient-quality FAF
images generally becomes feasible starting from 5 years
of age (Wabbels et al., 2006a). Short-wavelength excited
FAF origins from ﬂuorophores within the retinal pig-
ment epithelium (RPE), and RPE lipofuscin distribution
is the principal cause for the observed FAF patterns
(Delori et al., 1995a). Lipofuscin contains a mixture of
ﬂuorescent molecules that are by-products of the visual
cycle, many of which have not been thoroughly charac-
terized to date (Bui, Han, Radu, Travis, & Mata, 2006;0042-6989/$ - see front matter  2008 Elsevier Ltd. All rights reserved.
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Boulton, 2005).
The major lipofuscin ﬂuorophore is A2E, which exerts
diverse toxic eﬀects on the RPE (Lakkaraju, Finnemann,
& Rodriguez-Boulan, 2007; Sparrow & Boulton, 2005;
Sparrow & Cai, 2001; Sparrow, Cai, Jang, Zhou, & Nak-
anishi, 2006; Sparrow, Nakanishi, & Parish, 2000; Sparrow
et al., 2003b, 2003c; Weiter, Delori, Wing, & Fitch, 1986;
Zhou, Jang, Kim, & Sparrow, 2006). While the slight and
diﬀuse increase of lipofuscin with ageing is physiologic,
extensive and focal accumulation of lipofuscin is patho-
logic and may be encountered in a variety of retinal dystro-
phies (Delori, Goger, & Dorey, 2001; Sparrow et al.,
2003a,b; Weiter et al., 1986). Histopathological studies
have found an excessive accumulation of lipofuscin and/
or A2E in several retinal dystrophies, including those asso-
ciated with mutations in the ABCA4 gene, the VMD2
(BEST1) gene, and the peripherin/RDS gene (Bakall
et al., 2007; Mata, Weng, & Travis, 2000; Zhang, Gari-
baldi, Li, Green, & Zack, 2002). The present study illus-
trates the appearance of characteristic FAF patterns in
selected, relatively frequent retinal dystrophies.
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2.1. Autoﬂuorescence imaging
FAF imaging was performed with a confocal scanning laser ophthal-
moscope (cSLO, Heidelberg Retina Angiograph 2; Heidelberg Engineer-
ing, Dossenheim, Germany) and all images were acquired by the same
operator (CJFB). After pupil dilation to at least 6 mm with one drop of
phenylephrine and one drop of tropicamide, FAF imaging was performed
using the 30 ﬁeld of view and a resolution of 1536  1536 pixels, using an
optically pumped solid state laser (488 nm) for excitation. A barrier ﬁlter
at 500 nm suppressed the blue argon excitation light, so that reﬂectance
signals did not contribute to the FAF image obtained from the posterior
pole of the examined eye.
For the acquisition of FAF images, a standard procedure was fol-
lowed, which included focusing of the retinal image in the infrared reﬂec-
tion mode at 820 nm, sensitivity adjustment at 488 nm and acquisition of 9
single 30  30 FAF images which encompassed the entire macular area
and at least part of the optic disc. In order to improve the signal-to-noise
ratio of the FAF signal, the nine single images were aligned and a mean
image was calculated after detection and correction of eye movements
using the software provided by the manufacturer (Heidelberg Eye
Explorer, Heidelberg Engineering, Dossenheim, Germany). Images were
digitized and saved on hard disc for further analysis and processing. In
general, areas of increased FAF are believed to represent lipofuscin
increase either within or outside RPE cells, whereas decreased FAF may
indicate RPE cell death and atrophy of the RPE-photoreceptor complex.
2.2. Patients
A total of 112 patients with a variety of retinal dystrophies participated
in the study. All examinations were undertaken with the understanding
and written consent of each subject, and all procedures were conducted
in accordance with the Declaration of Helsinki. All patients were consec-
utively seen in a tertiary referral setting at the Department of Ophthalmol-
ogy of the Radboud University Nijmegen Medical Centre, Nijmegen, The
Netherlands.
We included 8 patients with autosomal recessive Stargardt disease–
fundus ﬂavimaculatus (STGD1), 27 patients with Best vitelliform macular
dystrophy (BVMD), 48 patients with central areolar choroidal dystrophy
(CACD), and 29 patients with some form of pattern dystrophy: 9 of these
patients had the adult-onset foveomacular vitelliform dystrophy (AFVD)
subtype, 16 patients were diagnosed with multifocal pattern dystrophy
simulating STGD1, one patient had butterﬂy-shaped pattern dystrophy
and 3 patients had pattern dystrophy related to ‘‘maternally inherited dia-
betes and deafness” (MIDD).Fig. 1. Fundus autoﬂuorescence (FAF) in autosomal recessive Stargardt
(p.Gly1961Glu and p.Lys969Arg mutations in ABCA4 gene), showing FAF ch
FAF surround the fovea, while the central fovea has a relatively normal appear
year-old patient with STGD1 (p.Gly863Ala and p.Arg2030X mutation in A
irregular ﬂecks of increased FAF, some of which are bordered by a zone of de
and the ﬂecks are most numerous in the nasal retina. These FAF changes
Composition of FAF images of a 20-year-old STGD1 patient (p.Tyr1779X and
the central macula. Outside this area, diﬀusely increased FAF is observed, wit
(B), the peripapillary retina is not spared by these FAF changes. The visual aIn all STGD1 patients, the diagnosis was conﬁrmed by the identiﬁca-
tion of 2 compound heterozygous mutations in the ABCA4 gene. In all 27
BVMD patients, the diagnosis was conﬁrmed by an absent light rise on the
electro-oculogram and the ﬁnding of a speciﬁc variant in the VMD2 gene.
All patients with CACD and multifocal pattern dystrophy simulating
STGD1, as well as the patient with butterﬂy-shaped pattern dystrophy,
carried mutations in the peripherin/RDS gene. The study population of
patients with multifocal pattern dystrophy simulating STGD1 was a sub-
set of recently reported patients (Boon et al., 2007a). In the AFVD
patients, no mutations in VMD2 or peripherin/RDS were identiﬁed. This
is in accordance with a recent study that found that mutations in these
genes are relatively rare in AFVD patients (Zhuk & Edwards, 2006).
The patients with MIDD-related pattern dystrophy carried a mitochon-
drial 3243A>G mutation.
After their medical history was obtained, all patients underwent an
extensive ophthalmic examination, including best-corrected Snellen visual
acuity, indirect ophthalmoscopy and fundus photography. In addition to
FAF imaging, subsequent examination included optical coherence tomog-
raphy and, in selected cases, ﬂuorescein angiography, electroretinography
and electro-oculography.3. Results
3.1. Autosomal recessive Stargardt disease–fundus
ﬂavimaculatus (STGD1)
In our study group, all STGD1 patients displayed FAF
abnormalities. Six STGD1 patients showed areas of focally
increased FAF, sometimes bordered by a zone of decreased
FAF. In addition, spots of decreased FAF were visible in
these patients. In two patients, these areas of altered
FAF were restricted to the macula (Fig. 1A), while four
patients showed a distribution of these ﬂecks throughout
or beyond the posterior pole. Many of these ﬂecks corre-
sponded with irregular yellowish ﬂecks at ophthalmoscopy,
but some ﬂecks of increased FAF were not seen at ophthal-
moscopy. The highest number of these extramacular ﬂecks
was seen in the nasal retina (Fig. 1B). Two patients showed
a diﬀusely increased FAF pattern throughout the fundus,
with a speckled pattern of small areas of decreased FAF.
In these patients, a large area of markedly decreased
FAF could be observed in the macula (Fig. 1C). Sevendisease (STGD1). (A) FAF image of a 30-year old STGD1 patient
anges that are restricted to the macula. Flecks of increased and decreased
ance. The visual acuity was 20/20. (B) Composition of FAF images of a 29-
BCA4 gene). The macula shows mottled FAF changes, surrounded by
creased FAF. The number of ﬂecks on FAF increases outside the macula,
are absent in the peripapillary area. The visual acuity was 20/200. (C)
IVS38-10T>C mutation in ABCA), displaying markedly decreased FAF in
h speckled areas of decreased FAF. In contrast to the patient described in
cuity was 20/200.
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lary zone, but one patient showed parapapillary FAF
abnormalities (Fig. 1C).3.2. Best vitelliform macular dystrophy
All patients with Best vitelliform macular dystrophy in
our study group displayed FAF abnormalities, except both
patients who were in the carrier stage, in whom FAF
abnormalities were either very discrete or absent
(Fig. 2A). At lesions in earlier stages, in which vitelliform
material appeared more abundant at ophthalmoscopy,
FAF imaging displayed areas of markedly increased
FAF. In the vitelliform stage, the round lesions showed
homogeneously increased FAF (Fig. 2B). In the
pseudohypopyon stage, FAF was visible mainly in the infe-
rior portion of the lesion, co-locating with the ophthalmo-
scopically visible pseudohypopyon (Fig. 2C). In the
vitelliruptive or scrambled-egg stage, the amount of auto-
ﬂuorescent material was reduced to a certain extent and
condensed mainly at the borders of the lesion, whereas
the central part of the lesion showed slightly decreased
FAF (Fig. 2D). In the atrophic stage, areas corresponding
with chorioretinal atrophy corresponded with a major
decrease of the FAF signal (Fig. 2E). Reduced FAF also
dominated in the cicatricial stage. However, some spots
of discretely increased FAF were present within these areas
of decreased FAF (Fig. 2F). In general, FAF imaging was
able to visualize even very small amounts of vitelliform
material that were not readily seen at ophthalmoscopy.Fig. 2. Fundus autoﬂuorescence (FAF) in Best vitelliform macular
dystrophy (BVMD). (A) Patient in the carrier stage, with no evident
FAF abnormalities. The visual acuity (VA) was 20/20. A p.Thr6Pro
variant in the VMD2 gene was found in this patient. (B) Vitelliform stage
of BVMD, showing a round macular lesion with intensely increased FAF,
corresponding with the yellow subretinal material seen at ophthalmos-
copy. This patient, who carried a p.Thr6Pro variant in VMD2, had a VA
of 20/20. (C) In the pseudohypopyon stage, material of highly increased
FAF is seen inferiorly. Some small spots of increased FAF are also
observed in the superior part of the lesion. This patient, carrying a
p.Thr6Pro variant in VMD2, had a VA of 20/20. (D) Vitelliruptive or
‘‘scrambled-egg” stage, showing a more dispersed localization of material
of increased FAF. This material is mainly situated at the borders of the
lesion, while the central part of the lesion shows some foci of increased
FAF. A p.Lys194_Ala195insVal mutation in VMD2 was identiﬁed in this
patient, who had a VA of 20/20. (E) Example of the atrophic stage,
showing a well-demarcated area absent FAF, corresponding with chori-
oretinal atrophy. This patient had a VA of 20/32, and carried a
p.Leu82Val variant in VMD2. (F) Composition of FAF images of a
patient in the cicatricial stage of BVMD, showing a central lesion of
reduced FAF, bordered by a ring-shaped zone of slightly increased FAF.
Two small extramacular lesions of increased FAF can also be observed.
The VA was 20/125, and a p.Thr6Pro variant in VMD2 was found in this
patient. (G) Patient with BVMD showing a spoke-like distribution of FAF
changes adjacent to a central area of decreased to absent FAF. A
p.Ala243Val variant was found in VMD2 in this patient, who had a VA of
20/25. (H) Example of FAF abnormalities in a patient with multifocal
vitelliform dystrophy, who carried a p.Gly299Ala variant in the VMD2
gene. A large suprapapillary lesion shows FAF changes that resemble
those in the central lesion. The VA was 20/80.
"Finally, one patient displayed a spoke-like pattern of
FAF changes simulating macular pattern dystrophy
(Fig. 2G), while another patient had multifocal vitelliform
lesions (Fig. 2H).3.3. Central areolar choroidal dystrophy
In central areolar choroidal dystrophy (CACD), we will
describe FAF characteristics in the stages of CACD as
described by Hoyng and Deutman (1996). In stage I
CACD, a discrete speckled increase of FAF was observed
in the parafoveal area (Fig. 3A). The FAF abnormalities
corresponding with early stage II involved a speckled,
round to oval area of predominantly increased FAF. This
area of abnormal FAF enlarged towards late stage II, and
the spots of increased FAF within the lesion decreased in
favour of speckles of decreased FAF. Stage III was charac-
terized by the appearance of extrafoveal, well-deﬁned areas
of absent FAF, which corresponded with chorioretinal
atrophy at ophthalmoscopy (Fig. 3B). These areas enlarged
and multiplied on follow-up (Fig. 3C). Stage IV CACD
Fig. 3. Fundus autoﬂuorescence (FAF) in central areolar choroidal dystrophy (CACD). All patients carried a p.Arg142Trp mutation in the peripherin/
RDS gene. (A) FAF image of stage I CACD with a diﬀuse parafoveal increase of FAF. The visual acuity was 20/20. (B) Early stage III CACD, showing
extrafoveal areas of absent FAF, corresponding with profound chorioretinal atrophy, on a background of speckled changes of increased and decreased
FAF. (C) Same patient as in panel (B), showing enlargement of the existing atrophic area after a follow-up period of 1.5 years. In addition, new regions of
absent FAF have appeared. The visual acuity was still 20/20. (D) Stage IV CACD, with a round macular lesion of absent FAF, bordered by a small band
of increased FAF. Note the discrete FAF of larger choroidal vessels underlying the lesion. The visual acuity was 20/800.
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absent FAF. Eventually, a round to oval area of virtually
absent FAF was seen in patients with end-stage CACD,
bordered by a small band of increased FAF (Fig. 3D).
3.4. Pattern dystrophies
3.4.1. Adult-onset foveomacular vitelliform dystrophy
The vitelliform lesions in the patients with AFVD corre-
sponded with round to oval lesions with increased FAF in
8 patients (Fig. 4A), sometimes with a small spot of
reduced FAF. Two patients had unilateral disease. In two
patients, zones of increased and decreased AF were seen
within the same lesion. One of these patients had lesions
displaying characteristics of scrambled-egg and pseudohy-
popyon. In another patient, the lesion in one eye showed
decreased FAF, corresponding with chorioretinal atrophy
at ophthalmoscopy. Small multifocal lesions of increased
FAF were seen in the macular area of one patient. In all
patients, lesions were smaller than one disc diameter on
FAF.
3.4.2. Multifocal pattern dystrophy simulating STGD1
In general, FAF in patients with multifocal pattern dys-
trophy simulating STGD1 shows changes that are very
similar to the FAF changes seen in patients with the fundus
ﬂavimaculatus subtype of STGD1. In multifocal pattern
dystrophy simulating STGD1, the STGD1-like ﬂecks dis-
played highly increased FAF, often with small adjacent
zones of decreased FAF (Fig. 4B). In a later stage, these
ﬂecks of increased FAF showed conﬂuence towards a large
ring-shaped area of mottled FAF abnormalities surround-
ing the macula and optic disc, without sparing of the para-
papillary retina (Fig. 4C). The changes could gradually
involve the macula (Fig. 4C). Within this ring-shaped area
of increased FAF, granular zones of substantially
decreased FAF appeared. After one or more decades of
disease, profound chorioretinal atrophy of the posterior
pole could occur, which corresponded with a severely
decreased or absent FAF signal. In the macular area,
FAF changes were variable. In 8 eyes, discrete spots ofeither increased or decreased FAF were seen in the fovea.
A group of irregular central ﬂecks of mostly increased
FAF, similar in shape, but generally larger than the periph-
eral ﬂecks, was seen in 7 eyes. In 8 eyes of 5 patients, large,
irregularly shaped lesions were seen, showing spots of
increased and decreased FAF. In one eye, a butterﬂy-
shaped lesion was seen on FAF as well as at ophthalmos-
copy. One or more well-deﬁned areas of severely decreased
FAF could be observed in 8 eyes of 5 patients, correspond-
ing with profound chorioretinal atrophy (Fig. 4C).
3.4.3. Butterﬂy-shaped pigment dystrophy
We examined one patient with butterﬂy-shaped pigment
dystrophy, in whom the butterﬂy-shaped lesions at oph-
thalmoscopy were also observed on FAF (Fig. 4D). The
pigmented part of the butterﬂy-shaped lesion showed
increased FAF, and was surrounded by decreased FAF.
3.4.4. Pattern dystrophy associated with maternally inherited
diabetes and deafness (MIDD)
In one MIDD patient, spots of decreased and increased
FAF were scattered throughout the macula, in one eye with
a central area of increased FAF corresponding with a
pseudovitelliform lesion at ophthalmoscopy (Fig. 4E).
Another patient displayed the same speckled aspect of
spots of increased and decreased FAF, with a relatively
normal FAF aspect of the fovea (Fig. 4F). The third
MIDD patient who displayed advanced FAF changes in
the posterior pole and around the optic nerve, showed
apparently normal FAF of both foveas, corresponding
with a normal visual acuity (Fig. 4G).
4. Discussion
In the present study, FAF abnormalities were
observed in all examined eyes with ophthalmoscopically
visible retinal dystrophies. Focally increased FAF was
the most common ﬁnding, frequently accompanied by
areas of decreased or even absent FAF. We observed
speciﬁc FAF abnormalities that were dependent on the
examined retinal disorder.
Fig. 4. Fundus autoﬂuorescence (FAF) in various pattern dystrophies. (A) FAF image of adult-onset foveomacular vitelliform dystrophy, showing a small
foveal lesion of increased FAF. This patient had a visual acuity (VA) of 20/32. No mutations were found in peripherin/RDS or VMD2. (B) FAF of a patient
with multifocal pattern dystrophy simulating STGD1, displaying irregular ﬂecks of markedly increased FAF, many of which show small adjacent zones of
decreasedFAF.TheFAFcharacteristics of these lesions in themacular area andalong the retinal vascular arcades are very similar to thoseobserved inSTGD1
(see Fig. 1B). The VA was 20/20. This patient carried a p.Asp145fsX30 mutation in the peripherin/RDS gene. (C) Advanced multifocal pattern dystrophy
simulating STGD1, with a large area of speckled increase and decrease of FAF extending beyond the retinal vascular arcades and optic disc. Multifocal,
well-circumscribed patches of absent FAF are observed within this area, corresponding with RPE atrophy on ophthalmoscopy. This patient had a VA of
20/25, and carried ap.Pro147fsX4mutation in peripherin/RDS. (D)FAF imageof a patientwithbutterﬂy-shapedpigmentdystrophy.Theopthalmoscopically
visible butterﬂy-shapedmacular changes are also seen onFAF, the pigmentedﬁgure showing increasedFAFsurroundedbydecreasedFAF.This patient, who
carried a p.Arg220fsX34 mutation in peripherin/RDS, had a VA of 20/20. (E) Patient with maternally inherited diabetes and deafness (MIDD)-associated
pattern dystrophy (m.3243A>Gmutation), showing a large pseudovitelliform macular lesion of increased FAF, surrounded by satellite lesions of increased
FAF and dispersed spots of decreased FAF. The visual acuity was 20/40. (F) Pattern dystrophy in a MIDD patient (m.3243A>G mutation) with speckled
changes of increased anddecreasedFAF in themacula and surrounding the optic disc. The foveal area shows a relatively normalFAFaspect. The visual acuity
was 20/20. (G) Advanced pattern dystrophy in a MIDD patient carrying the m.3243A>G mutation, showing irregular changes of increased and decreased
FAFalong the temporal retinal vascular arcades and surrounding the optic disc. Themacula shows a large area ofmarkedly decreased to absent FAFwith the
exception of a foveal island, which seems remarkably spared. The visual acuity was 20/20.
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Autosomal recessive Stargardt disease/fundus ﬂavima-
culatus (STGD1) is caused by mutations in the ABCA4
gene (Allikmets et al., 1997). With disease progression,
excessive increase of lipofuscin and especially A2E can be
observed, which is accelerated by light exposure (Cideciyan
et al., 2004; Delori et al., 1995a,b; Weng et al., 1999). This
abnormal increase of RPE lipofuscin is probably the ﬁrst
detectable pathophysiological change in STGD1 (Cideci-yan et al., 2004). Therefore, FAF imaging appears a prom-
ising method to monitor patients with STGD1 (Lois,
Halfyard, Bird, Holder, & Fitzke, 2004).
In our study, central macular lesions showed largely
decreased FAF, reﬂecting chorioretinal atrophy. In most
patients, these central lesions were surrounded by smaller,
well-circumscribed lesions of predominantly increased
FAF, largely corresponding with the irregularly shaped yel-
lowish ﬂecks that were observed at ophthalmoscopy. How-
ever, some of these lesions on FAF were not readily seen at
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detect pathologic changes in STGD1 in advance to clini-
cally visible abnormalities. Lesions were sometimes con-
ﬁned to the macula, but an innumerable amount of ﬂecks
of increased FAF, scattered throughout the retina, could
also be observed. Like in the normal retina (Delori et al.,
2001), the rate of lipofuscin accumulation in STGD1 shows
considerable intraretinal variation (Cideciyan et al., 2004,
2005a,b). A disease sequence of six stages has been pro-
posed by Cideciyan et al. (2004), based on lipofuscin accu-
mulation, retinoid cycle kinetics, as well as rod, cone and
RPE cell loss. Stage I shows entirely normal results, while
the only detectable abnormality in stage II is an increase
in mean FAF intensity. In stage III, these changes are super-
imposed by a focal increase of FAF intensity (Fig. 1A and
B). Diﬀerent FAF patterns have been described in STGD1,
which appear to correspond with functional abnormalities
(Gerth et al., 2002; Lois et al., 2004). Lesions tend to enlarge
and show conﬂuence, while the initially elevated FAF signal
evolves towards decreased to absent FAF intensities. These
decreasing FAF intensities are due to the loss of lipofuscin-
laden RPE cells, accompanied by increasing photoreceptor
degeneration and slowing of the retinoid cycle. In stage VI
(end-stage) ABCA4-related retinal degeneration, variably
sized regions of absent FAF are observed as a consequence
of complete RPE and photoreceptor degeneration.
In cases of STGD1 with abnormal cone and rod
responses on electroretinography, most patients show a
decreased FAF signal at the macula, sometimes in combi-
nation with patches of decreased FAF beyond the vascular
arcades, corresponding with chorioretinal atrophy. This
group of STGD1 patients also tends to show more visual
loss (Lois et al., 2004). Although there is no direct evidence
that conventional short-wavelength FAF accelerates the
disease process of ABCA4-related retinal dystrophies, there
are indications that some retinal degenerative diseases like
STGD1 may have lower light damage thresholds (Cideci-
yan et al., 2005a,b, 2007; Mata et al., 2000; Paskowitz,
Lavail, & Duncan, 2006). Therefore, some authors advo-
cate the use of reduced intensity FAF imaging (Cideciyan
et al., 2007; Paskowitz et al., 2006).
4.2. FAF in Best vitelliform macular dystrophy
BVMD is an autosomal dominant retinal dystrophy that
predominantly aﬀects the macula. BVMD is caused by
mutations in the VMD2 gene (Petrukhin et al., 1998). Typ-
ically, BVMD patients show bilateral round to oval yellow
subretinal lesions in the macula that resemble an egg-yolk
at a certain point of time (Gass, 1997). In a minority of
cases, multifocal vitelliform lesions may be encountered
(Boon et al., 2007b; Mullins, Oh, Heﬀron, Hageman, &
Stone, 2005). Most histopathological studies have found
an abnormal increase of RPE lipofuscin and A2E in the
RPE of donor eyes of BVMD patients (Bakall et al.,
2007; Frangieh, Green, & Fine, 1982; Mullins, Kuehn,
Faidley, Syed, & Stone, 2007; Mullins et al., 2005; O’Gor-man, Flaherty, Fishman, & Berson, 1988; Weingeist,
Kobrin, & Watzke, 1982).
In our study, FAF imaging allowed a detailed apprecia-
tion of the lesions in all BVMD patients. FAF was also
able to visualize small amounts of vitelliform material that
were not seen at ophthalmoscopy. In early stages, BVMD
lesions showed a predominantly increased FAF, which
decreased towards later stages. Previous studies indicate
that lesions may remain relatively constant in size (Wab-
bels, Preising, Kretschmann, Demmler, & Lorenz, 2006b),
but they may also enlarge when evolving to later stages
(Renner et al., 2005; Spaide, Noble, Morgan, & Freund,
2006). In virtually all patients, internal FAF characteristics
change substantially during follow-up (Wabbels et al.,
2006b). Lower visual acuity appears to be associated with
a more irregular pattern of increased FAF within the
lesion, due to scarring or hemorrhage (Jarc-Vidmar, Kraut,
& Hawlina, 2003; Wabbels et al., 2006b). In our study,
lesions in later stages of BVMD were characterized by a
generally decreased FAF. This gradual loss of FAF in later
disease stages indicates that this subretinal material of
increased FAF gradually disappears when RPE cell death
progresses and atrophy or scars develop.
4.3. FAF in central areolar choroidal dystrophy
Most cases of autosomal dominant CACD appear to be
associated with mutations in the peripherin/RDS gene, but
genetic heterogeneity has been described (Downes et al.,
1999; Hoyng et al., 1996; Hughes, Lotery, & Silvestri,
1998). In our study, patients with autosomal dominant
CACD showed increased FAF in the macular area early
in the course of the disease, suggesting lipofuscin accumu-
lation in the macular RPE. In late stage II CACD, zones of
decreased FAF may become more prominent, suggesting
gradual loss of RPE cells. Thus, our FAF ﬁndings indicate
a progressive lipofuscin accumulation and consecutive
RPE damage during the ﬁrst two stages. With time, lesions
may extend beyond the retinal vascular arcades and optic
nerve head (Downes et al., 1999; Keilhauer, Meigen, &
Weber, 2006). FAF in stage III CACD shows sharply
demarcated areas of severely decreased to absent FAF.
These atrophic areas develop within areas of speckled
FAF changes. Therefore, these initial diﬀusely RPE aﬀec-
tions may result in regions of total loss of RPE, which
enlarge and ﬁnally involve the foveal RPE in end-stage
CACD. In this stage, a well-deﬁned, round to oval area
of absent FAF is seen, bordered by a small area of
increased FAF. Interestingly, FAF abnormalities may pre-
cede ophthalmoscopically visible changes in CACD (Dow-
nes et al., 1999). This makes FAF imaging especially
suitable for non-invasive screening of families with CACD.
4.4. FAF in pattern dystrophies
The phenotypically and genetically heterogeneous group
of pattern dystrophies is characterized by a variety of
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in the macular area (Francis et al., 2005; Marmor & Byers,
1977; Pinckers, 1988; Weigell-Weber, Kryenbuhl, Buchi, &
Spiegel, 1996). The classiﬁcation of Gass discriminates
between ﬁve main categories of pattern dystrophies:
adult-onset foveomacular vitelliform dystrophy (AFVD),
butterﬂy-shaped pigment dystrophy, reticular dystrophy
of the pigment epithelium, multifocal pattern dystrophy
simulating fundus ﬂavimaculatus (MPD), and fundus pul-
verulentus (Gass, 1997). In the group of AFVD patients in
the present study, all lesions were smaller than one disc
diameter in size and generally showed increased FAF.
These results correspond with previous FAF ﬁndings in
AFVD patients and with the histopathologic ﬁnding of
increased lipofuscin in AFVD lesions (Dubovy et al.,
2000; Patrinely, Lewis, & Font, 1985; Renner et al.,
2004). One patient showed small multifocal lesions of
increased FAF, while another patient had lesions with a
scrambled-egg and pseudohypopyon aspect, features that
are also seen in BVMD.
In patients with MPD, which is often caused by peri-
pherin/RDS mutations, the posterior pole may be scat-
tered with irregular ﬂecks mimicking STGD1 on FAF,
as well as on ophthalmoscopy and optical coherence
tomography (Boon et al., 2007a). Like in STGD1, the
ﬂecks in MPD may extend beyond the macular area.
In later stages, these ﬂecks may show conﬂuence to a
ring-shaped area of abnormal FAF, surrounding the
macula and optic disc. Central macular lesions show a
broad range of FAF changes, often with predominantly
increased FAF, especially in earlier stages. In time, mac-
ular lesions may also show markedly decreased FAF due
to profound chorioretinal atrophy. Therefore, it may be
diﬃcult to discriminate between STGD1 and MPD on
the basis of the FAF aspect. Distinguishing features
between MPD and STGD1 are the autosomal dominant
pattern of inheritance, the relatively late age at onset, the
comparatively good and stable visual acuity and the
absence of a ‘‘dark choroid” on ﬂuorescein angiography
(Boon et al., 2007a). Molecular genetic analysis may aid
in the diﬀerential diagnosis between these diﬀerent
entities.
In butterﬂy-shaped pigment dystrophy, patients display
macular lesions with a spoke-like pigment pattern sur-
rounded by a zone of depigmentation, thus somewhat
resembling the shape of a butterﬂy (Deutman, van
Blommestein, Henkes, Waardenburg, & Solleveld-van Dri-
est, 1970). The phenotype of butterﬂy-shaped pigment dys-
trophy is genetically heterogeneous (van Lith-Verhoeven,
Cremers, van den Helm, Hoyng, & Deutman, 2003; Zhang
et al., 2002). In a case caused by a peripherin/RDS missense
mutation (Cys213Tyr), increased amounts of lipofuscin
have been found in the RPE on histopathologic examina-
tion (Zhang et al., 2002). This corresponds with the ﬁnding
in our study of increased FAF of the pigmented part of the
lesion in the patient with butterﬂy-shaped pigment
dystrophy.Pattern dystrophy phenotypes may also be associated
with syndromes, such as myotonic dystrophy, pigment dis-
persion syndrome, and mitochondrial syndromes like
maternally inherited diabetes and deafness (MIDD) and
MELAS (mitochondrial encephalomyopathy, lactic acido-
sis, and stroke-like episodes) syndrome (Chew & Deutman,
1983; Chew, Deutman, & Cruysberg, 1985; Hayasaka
et al., 1984; Isashiki et al., 1998; Massin et al., 1999).
MIDD and MELAS are associated with mutations in the
mitochondrial DNA, the 3243A>G point mutation being
the most frequently identiﬁed mutation (Malecki, 2005).
As much as 86% of patients with maternally inherited dia-
betes and deafness (MIDD) may show some form of pat-
tern dystrophy. In our study, RPE changes in MIDD
patients were easily deﬁned on FAF as speckled areas of
increased and decreased FAF in the macula and surround-
ing the optic disc. The intriguing feature of foveal sparing
(Bellmann et al., 2004) can be observed on FAF in a
MIDD patient with advanced pattern dystrophy, which is
illustrated in Fig. 4G.
5. Conclusions
FAF imaging is a useful tool for the identiﬁcation and
follow-up of lesions associated with lipofuscin accumula-
tion or RPE cell loss. As such, FAF imaging may yield
important additional information in a diagnostic setting
in relatively frequent retinal dystrophies such as STGD1,
BVMD and in retinal dystrophies associated with periphe-
rin/RDS mutations. FAF may visualize more lesions com-
pared to ophthalmoscopy. Moreover, FAF imaging
provides qualitative information, as it reﬂects the lipofuscin
content in lesions, and FAF changes appear to relate to
functional abnormalities in at least some retinal dystro-
phies (Lois et al., 2004; Robson et al., 2003, 2006). How-
ever, non-lipofuscin accumulating parts of a lesion may
be missed with FAF. Therefore, FAF alone may not be
useful for lesion size measurement.
Retinal dystrophies may present with a considerable
clinical variability. Late stages with RPE cell loss may
look similar in various retinal dystrophies and in other
retinal disorders such as age-related macular degenera-
tion. In this respect, FAF may be of limited use in the dif-
ferential diagnosis between diﬀerent forms of retinal
dystrophy. Molecular genetic testing may be very helpful
in these cases. Compared to ﬂuorescein angiography,
FAF imaging, as a non-invasive imaging modality, is a
straightforward and relatively patient-friendly means to
get an overview of the accumulation of ﬂuorophores like
lipofuscin and atrophic changes within the RPE-photore-
ceptor complex (Delori et al., 1995a,b; von Ru¨ckmann
et al., 1997). Therefore, FAF imaging may constitute a
convenient tool for cross-sectional and family studies, as
well as in the follow-up of various retinal dystrophies.
In addition, FAF imaging may also play a role as a
parameter for the evaluation of therapeutic eﬀects in
future clinical treatment trials.
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